Recall
FDAHealthNovember 5, 2024

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories — Hydralazine HCl Tablets, USP, 25mg, Rx only, 100 tablets per carton, Distributed by: Avet Pharmaceuticals Inc., East Bruns

⚠️ Failed Impurities/Degradation Specifications; during routine stability testing for impurities.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
November 5, 2024

Nationwide in the US.

What's affected?

Product
Hydralazine HCl Tablets, USP, 25mg, Rx only, 100 tablets per carton, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, Distributed by: MAJOR Pharmaceuticals, Livonia, MI, 48152, USA, NDC 0904-6441-61.
Lot code
T04888

Additional details

Lot#: T04888, Exp 11/2024; T04946, Exp 12/2024; T04970, Exp 07/2025

What should I do?

Recommended action

Class III recall. Voluntary: Firm initiated Quantity affected: 25814 tablets.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.